Latest Operational Costs News

RooLife Group (ASX, RLG) reported $1 million revenue in Q4 FY2025, driven by its UK TikTok marketplace launch and a major solar product order from India, while divesting its digital marketing arm and cutting staff costs.

Papyrus Australia has made significant strides in Q2 2025, launching its Rapid Prototyping and R&D Facility and successfully trialling new banana fibre-based products, while deepening academic partnerships.

Atlantic Lithium advances negotiations for revised fiscal terms on its flagship Ewoyaa Mining Lease in Ghana, while reporting promising spodumene discoveries in Côte d'Ivoire and implementing significant cost-saving measures.

Australian Oil Company Limited reported stable gas production from key wells and completed a $1 million loan forgiveness settlement, while refocusing its portfolio away from less promising leases.

Atomos Limited faced a challenging Q4 FY25 with US tariff disruptions but rebounded strongly in June, launching new products and appointing Peter Barber as CEO to drive future growth.

Gathid Ltd reported a robust 14% quarterly increase in Annual Recurring Revenue to $1.936 million, driven by new customer wins and expansions, even as a legal dispute over its physical security business sale remains unresolved.

NoviqTech Limited has expanded its sustainability technology footprint through key partnerships in hydrogen and battery recycling, secured a significant grant extension, and announced a $1.25 million capital raise to fuel growth.

Argent BioPharma has achieved a significant milestone by commencing formal supply of its EU-GMP cannabinoid API for epilepsy treatment at a leading Slovenian hospital and gaining prescription approval for CannEpil™ in Germany, marking key steps in its European expansion.

State Gas Limited has successfully drilled two new wells at its Rolleston West Project, intersecting significant coal seams and initiating production testing, while engaging NSAI for independent reserve certification.

Elixinol Wellness reported a 10.8% revenue increase in Q2 2025, supported by improved cash receipts and a focused cost containment program. The company secured new funding and launched a menopause-targeted product, positioning itself for margin growth and profitability in H2.

Invion Limited has secured a $20,000 grant to support its anogenital cancer trial and progressed its skin cancer study with promising early results, while raising approximately $1 million through a Loyalty Option Entitlement Offer.

Cobalt Blue Holdings has completed a promising scoping study for its Halls Creek copper-zinc-silver project and secured a key cobalt feedstock contract with Glencore, setting the stage for a final investment decision on its Kwinana Cobalt Refinery by year-end.